
APOPTOSIS GENE EXPRESSION PROFILE IN
EARLY-STAGE NON SMALL CELL LUNG CANCER Metodieva SN1, Cherneva RV, Nikolova DN,
Genchev GD, Petrov DB, Toncheva DI *Corresponding Author: Svetlana Nikolova Metodieva, Department of Medical Genetics,
Medical University Sofia, 2 Zdrave str, 1431 Sofia, Bulgaria; Tel.: +359-2-952-0357; Fax: +359-
2-952-0357; E-mail: svetlana.metodieva@yahoo.com page: 47
|
RESULTS
Using the web-based PCR Array Data Analysis
software we calculated the expression of each gene
in the tumor tissue compared to the mean value of
expression in adjacent non tumor tissues. Genes
with altered expression and their average fold
regulation values are presented in Table 2.
Using the set criterion, none of the 84 analyzed
genes were up regulated, while six genes were down
regulated in the tumor tissues. Of the underexpressed
genes, two were caspases and members of the death
effector domain family, CASP8 and CASP10.
Other substantially down regulated genes include
BCL10 containing caspase recruitment domains
(representing the CARD family) and tumor necrosis
factor superfamily 8 (TNFSF8), a TNF ligand family
member. The death domain-containing gene DAPK1
showed the most stable underexpression being down
regulated in eight of the 12 NSCLC cases. From
the BCL2 related family members, slight down
regulation was shown for MCL1 (Table 2).
We performed separate analyses of gene
expression in the AC and SCC histological subtypes
of NSCLC. In AC, we found the BCL2 family
member HRK to be down regulated in five out of
seven cases, while in SCC it was up regulated in
four out of five cases although it was below the
set threshold in three of them. The SCC histotype
showed underexpression of DAPK1 in four out of
five cases, while four out of seven ACs showed
underexpression of this gene.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|